These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 37163241)
1. Surfactant administration during endotracheal CPAP-Is DD-Surf comparable to LISA? Khurana S Acta Paediatr; 2023 Aug; 112(8):1808-1809. PubMed ID: 37163241 [No Abstract] [Full Text] [Related]
2. Surfactant administration during endotracheal CPAP: Feasibility, risk factors for failure and short-term outcomes of DD-SURF. Mense L; Hansmann T; Seipolt B; Kaufmann M; Rüdiger M Acta Paediatr; 2023 Aug; 112(8):1653-1658. PubMed ID: 36946356 [TBL] [Abstract][Full Text] [Related]
3. The effect of less invasive surfactant administration on cerebral oxygenation in preterm infants. Hanke K; Rausch TK; Paul P; Hellwig I; Krämer C; Stichtenoth G; Herz A; Wieg C; König IR; Göpel W; Herting E; Härtel C Acta Paediatr; 2020 Feb; 109(2):291-299. PubMed ID: 31310677 [TBL] [Abstract][Full Text] [Related]
4. Should less invasive surfactant administration (LISA) become routine practice in US neonatal units? Kakkilaya V; Gautham KS Pediatr Res; 2023 Apr; 93(5):1188-1198. PubMed ID: 35986148 [TBL] [Abstract][Full Text] [Related]
5. Caffeine and Less Invasive Surfactant Administration for Respiratory Distress Syndrome of the Newborn. Katheria A; Ines F; Banerji A; Hopper A; Uy C; Chundu A; Coughlin K; Hutson S; Morales A; Sauberan J; Poeltler D; Dorner R; Rich W; Finer N NEJM Evid; 2023 Dec; 2(12):EVIDoa2300183. PubMed ID: 38320499 [TBL] [Abstract][Full Text] [Related]
6. Less invasive surfactant administration methods: Who, what and how. Guthrie SO; Roberts KD J Perinatol; 2024 Apr; 44(4):472-477. PubMed ID: 37737494 [TBL] [Abstract][Full Text] [Related]
7. Author's response to 'Surfactant administration during endotracheal CPAP-Is DD-SURF comparable to LISA?'. Mense L; Rüdiger M Acta Paediatr; 2023 Aug; 112(8):1810-1811. PubMed ID: 37166439 [No Abstract] [Full Text] [Related]
8. Cost-saving effect of early less invasive surfactant administration versus continuous positive airway pressure therapy alone for preterm infants with respiratory distress syndrome. Federici C; Fornaro G; Roehr CC Eur J Hosp Pharm; 2022 Nov; 29(6):346-352. PubMed ID: 33658228 [TBL] [Abstract][Full Text] [Related]
9. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants. Kaniewska U; Gulczyńska E Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994 [TBL] [Abstract][Full Text] [Related]
10. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial. Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290 [TBL] [Abstract][Full Text] [Related]
11. Surfactant administration in preterm babies (28-36 weeks) with respiratory distress syndrome: LISA versus InSurE, an open-label randomized controlled trial. Mishra A; Joshi A; Londhe A; Deshmukh L Pediatr Pulmonol; 2023 Mar; 58(3):738-745. PubMed ID: 36416036 [TBL] [Abstract][Full Text] [Related]
12. A systematic review of surfactant delivery via laryngeal mask airway, pharyngeal instillation, and aerosolization: Methods, limitations, and outcomes. Devi U; Roberts KD; Pandita A Pediatr Pulmonol; 2022 Jan; 57(1):9-19. PubMed ID: 34559459 [TBL] [Abstract][Full Text] [Related]
13. Less invasive surfactant administration (LISA) - ways to deliver surfactant in spontaneously breathing infants. Herting E Early Hum Dev; 2013 Nov; 89(11):875-80. PubMed ID: 24075206 [TBL] [Abstract][Full Text] [Related]
14. Less invasive surfactant administration: best practices and unanswered questions. Herting E; Härtel C; Göpel W Curr Opin Pediatr; 2020 Apr; 32(2):228-234. PubMed ID: 32068592 [TBL] [Abstract][Full Text] [Related]
15. Should premedication be used for less invasive surfactant administration (LISA)? Yew R; Fleeman M; Gowda H Arch Dis Child; 2023 Feb; 108(2):141-143. PubMed ID: 36446482 [No Abstract] [Full Text] [Related]
18. Multicentre, randomised trial of preterm infants receiving caffeine and less invasive surfactant administration compared with caffeine and early continuous positive airway pressure (CaLI trial): study protocol. Ines F; Hutson S; Coughlin K; Hopper A; Banerji A; Uy C; Finer N; Rich W; Morales A; Steen J; Katheria AC BMJ Open; 2021 Jan; 11(1):e038343. PubMed ID: 33483435 [TBL] [Abstract][Full Text] [Related]
19. Effects of less invasive surfactant administration (LISA) via a gastric tube on the treatment of respiratory distress syndrome in premature infants aged 32 to 36 weeks. Yang G; Hei M; Xue Z; Zhao Y; Zhang X; Wang C Medicine (Baltimore); 2020 Feb; 99(9):e19216. PubMed ID: 32118723 [TBL] [Abstract][Full Text] [Related]
20. Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China. Xu CC; Bao YY; Zhao JX; Cheng K; Sun L; Wu JY; Wu MY; Zhu JJ BMC Pulm Med; 2022 Dec; 22(1):462. PubMed ID: 36471386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]